Bioorthogonal Cu-MOF nanocatalyst enables GSH-triggered in situ drug synthesis for xCT-driven ferroptosis in colorectal cancer

Journal of Controlled Release 2026

View at publisher
Authors: Sahil Chahal, Amal Babu, Arathy Vasukutty, In-kyu Park
DOI: 10.1016/j.jconrel.2026.114775
Cited by: 2
References: 19

Fields of Study & Subjects

Nanoplatforms for cancer theranostics Ferroptosis and cancer prognosis Nanocluster Synthesis and Applications

Publication details

Journal / source
Journal of Controlled Release
Publisher
Elsevier BV
Volume
393
Pages
114775–114775
Publication date
3 March 2026
Language
EN